Benzoxazolinone aryl sulfonamides as potent, selective Nav1.7 inhibitors with in vivo efficacy in a preclinical pain model

Benzoxazolinone aryl sulfonamides as potent, selective Nav1.7 inhibitors with in vivo efficacy in a preclinical pain model

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Bioorganic & Medicinal Chemistry Letters - Volume 27, Issue 12, 15 June 2017, Pages 2683-2688

Joseph E. Pero, Michael A. Rossi, Hannah D.G.F. Lehman, Michael J. III, James J. Mulhearn, Scott E. Wolkenberg, Matthew J. Cato, Michelle K. Clements, Christopher J. Daley, Tracey Filzen, Eleftheria N. Finger, Yun Gregan, Darrell A. Henze,